|
|
Home > Healthcare > Biotechnology > General Biotech
The 2009-2014 World Outlook for Biological Veterinary Vaccines, Bacterins, Toxoids, Other Antigens, and Other Biological Products
|
|
This econometric study covers the world outlook for biological veterinary vaccines, bacterins, toxoids, other antigens, and other biological products across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created.
This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world).
This study gives, however, my estimates for the worldwide latent demand, or the P.I.E., for biological veterinary vaccines, bacterins, toxoids, other antigens, and other biological products. It also shows how the P.I.E. is divided across the world’s regional and national markets. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.
|
Similar Products
• Algae For Fuel, Algal Oil, Biofuels, Biodiesel, Ethanol And The Future Of Petroleum And Green Energy
Published Nov 2009 by Amadee & Company
• Biotechnology (Pharmaceuticals) Report
Published Nov 2009 by Plimsoll Publishing Ltd.
• Opportunities in Human Embryonic Stem Cell (hESC) Products
Published Nov 2009 by BioInformant Worldwide, L.L.C.
• Global Stem Cell and Advanced Technologies Market
Published Nov 2009 by MarketsandMarkets
• Protein Kinase Therapeutics in Oncology - Where to Commercialize?
Published Oct 2009 by BioSeeker Group AB
• Acorda Therapeutics, Inc. - SWOT Analysis
Published Oct 2009 by Datamonitor
• Future of Green Biotechnology in China
Published Oct 2009 by CCM International Limited
• Scientific Research in Australia - Industry Risk Rating Report
Published Oct 2009 by IBISWorld
• Biotechnology in Australia - Industry Risk Rating Report
Published Oct 2009 by IBISWorld
• Biotechnology in the US - Industry Risk Rating Report
Published Oct 2009 by IBISWorld
|
|
|
|
0 items
